Naloxone intranasal - AntiOp

Drug Profile

Naloxone intranasal - AntiOp

Alternative Names: Naloxone nasal spray

Latest Information Update: 01 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AntiOp
  • Developer AntiOp; Indivior
  • Class Antidotes; Morphinans; Small molecules
  • Mechanism of Action Opioid mu receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Opioid abuse

Most Recent Events

  • 29 Jul 2015 Preregistration for Opioid abuse in USA (Intranasal)
  • 29 Jul 2015 Naloxone intranasal receives priority review status for Opioid abuse in USA
  • 15 Jul 2014 Naloxone intranasal - AntiOp receives Fast Track designation for Opioid abuse [Intranasal,Spray] in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top